For decades, VMware was the bedrock of IT infrastructure. But the ground is violently shifting with sweeping changes to its pricing, platform strategies, and partner ecosystems. Gartner predicts that by 2028, a staggering 70% of enterprise-scale VMware customers will leave, migrating half of their virtual workloads due to cost concerns. And this is no small decision either, but the "breakdown of a 20+ year ecosystem." The question isn't if you'll modernize, but how you'll navigate this new, fractured landscape.

Download this whitepaper to arm yourself with the insights needed to make informed, future-proof decisions. Cut through the noise, spotlighting "smarter, more flexible ways to build for the future" and dive into the leading enterprise-scale alternatives like Nutanix and KubeVirt that are redefining what’s possible beyond VMware.

Key takeaways:

• The VMware exodus: After decades of dominance, understand why 82% of IT executives are planning to reduce or eliminate VMware usage.
• Cost tsunami: Learn why Gartner projects that by 2028, 70% of enterprise VMware users will migrate 50% of their workloads due to these concerns.
• Nutanix rising: See how Nutanix's hyperconverged infrastructure (HCI) with its license-free AHV hypervisor offers a path to reduced costs, streamlined operations, and architectural flexibility.
• KubeVirt's Kubernetes edge: Discover KubeVirt, an open-source project enabling you to run VMs alongside containers within Kubernetes.
• The broader battlefield: Get a concise overview of other significant players, including Microsoft Hyper-V for Windows-centric shops, OpenStack for scalable private/hybrid clouds, and options like Proxmox VE for smaller teams.
• Cloud-native contenders: Understand the role of native virtualization services from AWS, Azure, and Google Cloud, especially for DevOps teams and cloud-first strategies.
• Storage solutions: See how Pure Storage can underpin these new strategies, offering high-performance, scalable storage for Nutanix and supporting KubeVirt through Portworx.